Wednesday, February 10, 2010, 8:01pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Enzo Biochem Inc. (ENZ)

At 5:02AM SGT: 4.81 USD   0.00 (0.00%)  
 MORE ON ENZ 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ENZO BIOCHEM INC (NYSE:ENZ) Delayed quote dataEdit
Last Trade:4.81 USD
Trade Time:5:02AM SGT
Change: 0.00 (0.00%)
Prev Close:4.81
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:14.00
Day's Range:N/A - N/A
52wk Range:2.70 - 7.98
Volume:0
Avg Vol (3m):172,533
Market Cap:182.10M
P/E (ttm):N/A
EPS (ttm):-0.51
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ENZ to Portfolio   Download Data

 HEADLINES 
•ENZO BIOCHEM INC Files SEC form 8-K, Other Events
EDGAR Online (Sat, Jan 30)
•Enzo Biochem is Well Positioned for New Paradigms in Biotech and Healthcare, Annual Meeting is Told
Business Wire (Fri, Jan 29)
•ENZO BIOCHEM INC Files SEC form 8-K, Other Events
EDGAR Online (Thu, Jan 28)
•Enzo Biochem Reports That Its Clinical Labs Division Has Available Newly Authorized Swine Flu (H1N1) Test
Business Wire (Thu, Jan 14)
•ENZO BIOCHEM INC Financials
EDGAR Online Financials (Thu, Dec 17)
•Health Care Companies With Wide Coverage Reach In Certain States Will Benefit Greatly From The $400 Billion To Be Spent By Medicaid
Wall Street Transcript (Tue, Dec 15)
•New Star Analyst Rankings for ENZO BIOCHEM INC
StarMine (Sat, Dec 12)
•Enzo Biochem, Inc.: Warming Up or Cooling Off?
at Motley Fool (Sat, Dec 12)
•ENZO BIOCHEM INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financi
EDGAR Online (Fri, Dec 11)
•Enzo Biochem 1Q loss narrows on revenue boost
AP (Fri, Dec 11)
More Headlines for ENZ...
 ANALYST 
EPS Est (next year) (Jul-10) :-0.26
EPS Est (in 2 years) (Jul-11) :-0.23
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Enzo Biochem, Inc., a life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices